Christophe Lahorte

753 total citations
19 papers, 583 citations indexed

About

Christophe Lahorte is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christophe Lahorte has authored 19 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 12 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christophe Lahorte's work include Radiopharmaceutical Chemistry and Applications (13 papers), S100 Proteins and Annexins (9 papers) and Cell death mechanisms and regulation (7 papers). Christophe Lahorte is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (13 papers), S100 Proteins and Annexins (9 papers) and Cell death mechanisms and regulation (7 papers). Christophe Lahorte collaborates with scholars based in Belgium, Italy and France. Christophe Lahorte's co-authors include Christophe Van de Wiele, Guido Slegers, Rudi Dierckx, Neil Steinmetz, Jean‐Luc Vanderheyden, Hubert Vermeersch, David S. Loose, R. A. Dierckx, Claude Cuvelier and Wim J.G. Oyen and has published in prestigious journals such as Journal of Clinical Oncology, Critical Care Medicine and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Christophe Lahorte

19 papers receiving 576 citations

Peers

Countries citing papers authored by Christophe Lahorte

Since Specialization

Citations

This map shows the geographic impact of Christophe Lahorte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Lahorte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Lahorte more than expected).

Fields of papers citing papers by Christophe Lahorte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christophe Lahorte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Lahorte. The network helps show where Christophe Lahorte may publish in the future.

Co-authorship network of co-authors of Christophe Lahorte

This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Lahorte. A scholar is included among the top collaborators of Christophe Lahorte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Lahorte. Christophe Lahorte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	99mTc-HYNIC Annexin-V imaging of tumors and its relationship to response to radiotherapy and/or chemotherapy. 2007 ·PubMed ·Sylvie Rottey, David S. Loose, Luc Vakaet, Christophe Lahorte, Hubert Vermeersch, Simon Van Belle, Christophe Van de Wiele	24
2	ANNEXIN V DETECTION OF LIPOPOLYSACCHARIDE-INDUCED CARDIAC APOPTOSIS 2006 ·Shock ·(unknown), Christophe Lahorte, Elena Bonanno, Alberto Signore, Steve Lancel, Philippe Marchetti, B. Vallet, Guido Slegers, Rémi Nevière	13
3	Expression of apoptosis regulatory factors during myocardial dysfunction in endotoxemic rats* 2005 ·Critical Care Medicine ·Steve Lancel, (unknown), Raphaël Favory, (unknown), Christophe Lahorte, (unknown), B. Vallet, Philippe Marchetti, Rémi Nevière	27
4	In vivo apoptosis detection with radioiodinated Annexin V in LoVo tumour-bearing mice following Tipifarnib (Zarnestra, R115777) farnesyltransferase inhibitor therapy 2005 ·Nuclear Medicine and Biology ·Bart Cornelissen, Christophe Lahorte, Veerle Kersemans, Gabriela Capriotti, Elena Bonanno, Alberto Signore, Christophe Van de Wiele, Rudi Dierckx, Guido Slegers	8
5	Intraobserver, Interobserver, and Day-to-Day Reproducibility of Quantitative ^99m Tc-HYNIC Annexin-V Imaging in Head and Neck Carcinoma 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·Hubert Vermeersch, Hamphrey Ham, Sylvie Rottey, Christophe Lahorte, (unknown), Rudi Dierckx, Neil Steinmetz, Christophe Van de Wiele	23
6	Apoptosis-detecting radioligands: current state of the art and future perspectives 2004 ·European Journal of Nuclear Medicine and Molecular Imaging ·Christophe Lahorte, Jean‐Luc Vanderheyden, Neil Steinmetz, Christophe Van de Wiele, Rudi Dierckx, Guido Slegers	155
7	Influence of farnesyl transferase inhibitor treatment on epidermal growth factor receptor status 2004 ·Nuclear Medicine and Biology ·Bart Cornelissen, (unknown), Veerle Kersemans, Christophe Van de Wiele, Christophe Lahorte, Rudi Dierckx, Guido Slegers	6
8	99mTc-HYNIC Annexin-V imaging of primary head and neck carcinoma 2004 ·Nuclear Medicine Communications ·Hubert Vermeersch, David S. Loose, Christophe Lahorte, (unknown), Rudi Dierckx, Neil Steinmetz, Jean‐Luc Vanderheyden, Claude Cuvelier, Guido Slegers, Christophe Van de Wiele	28
9	Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinoma 2004 ·European Journal of Nuclear Medicine and Molecular Imaging ·Hubert Vermeersch, (unknown), Christophe Lahorte, David S. Loose, (unknown), Neil Steinmetz, Claude Cuvelier, Guido Slegers, Christophe Van de Wiele	9
10	Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo. 2004 ·PubMed ·Christophe Lahorte, Klaus Bacher, Ingrid J.G. Burvenich, Elisabeth Coene, Claude Cuvelier, Christian De Potter, Hubert Thierens, Christophe Van de Wiele, Rudi Dierckx, Guido Slegers	5
11	Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans 2003 ·Nuclear Medicine Communications ·Christophe Lahorte, Christophe Van de Wiele, Klaus Bacher, Bieke Van Den Bossche, Hubert Thierens, Simon Van Belle, Guido Slegers, R. A. Dierckx	37
12	In vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage 2003 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Filip De Vos, Fritz Offner, Jan Philippé, Christos Apostolidis, R. Molinet, Tuomo Nikula, Klaus Bacher, (unknown), Anne Vral, Christophe Lahorte, Hubert Thierens, Rudi Dierckx, Guido Slegers	27
13	2003 ·Nuclear Medicine Communications ·Christophe Lahorte, Christophe Van de Wiele, Klaus Bacher, Bieke Van Den Bossche, Hubert Thierens, Simon Van Belle, Guido Slegers, R. A. Dierckx	4
14	Quantitative Tumor Apoptosis Imaging Using Technetium-99m–HYNIC Annexin V Single Photon Emission Computed Tomography 2003 ·Journal of Clinical Oncology ·Christophe Van de Wiele, Christophe Lahorte, Hubert Vermeersch, David S. Loose, (unknown), Neil Steinmetz, Jean‐Luc Vanderheyden, Claude Cuvelier, Guido Slegers, (unknown)	98
15	Nuclear medicine imaging to predict response to radiotherapy: a review 2002 ·International Journal of Radiation OncologyBiologyPhysics ·Christophe Van de Wiele, Christophe Lahorte, Wim J.G. Oyen, Otto C. Boerman, Ingeborg Goethals, Guido Slegers, Rudi Dierckx	65
16	Synthesis and in vitro evaluation of 123I-labelled human recombinant annexin V 2001 ·Biomolecular Engineering ·Christophe Lahorte, Guido Slegers, Jan Philippé, Christophe Van de Wiele, R. A. Dierckx	32
17	The myocardial uptake of ¹²³I — annexin V is increased in septic rats 2001 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Christophe Lahorte, (unknown), Rémi Nevière, (unknown), Guido Slegers	4
18	Synthesis and in vitro stability of123I-labelled annexin V: a potential agent for spect imaging of apoptotic cells 2000 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Christophe Lahorte, F. Dumont, Guido Slegers, Christophe Van de Wiele, R. A. Dierckx, (unknown)	14
19	4. Synthesis, biodistribution and dosimetry studies of 123I-labelled Annexin V in mice: A potential SPET-ligand for visualisation of apoptotic cells 1999 ·Nuclear Medicine Communications ·Christophe Lahorte, F. Dumont, Guido Slegers, (unknown), R. A. Dierckx	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact